Jeantine Lunshof is a philosopher and bioethicist and is Assistant Professor at the Department of Genetics, University Medical Center Groningen, The Netherlands. She obtained her Bachelor’s degree in Philosophy with a minor in Tibetan Language & Culture at Hamburg University (Germany) and graduated in Philosophy with a minor in Health Law at the University of Amsterdam. She obtained her PhD degree at VU University with a thesis concerning the impact that developments in genomic sciences have on practical ethics and normative theory. Next to her studies at the University of Amsterdam, Jeantine trained as a nurse in a hospital-based nursing school and upon receiving her RN she worked for almost 10 years in the research clinic of the Netherlands Cancer Institute in Amsterdam.
After holding a Marie Curie Fellowship from 2013 till 2016, Jeantine currently works at the University of Groningen and at Harvard Medical School, Department of Genetics (Church lab), where she pursues a research program on systems biology-based concepts of health and disease and on normative models for genomic sciences and biological engineering. She is ethics consultant with the Personal Genome Project since 2006, and with the past and the current Center for Excellence in Genomic Science: Causal Consequences of Variation (CCV, 2010-2015), and Center for Genomically Engineered Organs (CGEO, 2015-present) at Harvard Medical School. In 2006, she developed the innovative model of Open Consent that forms the normative backbone of the Personal Genome Project. Jeantine has been Ethics Advisory Board Member for two large European Commission-funded research consortia, she is Affiliate Member of the NIH Pharmacogenomics Research Network, and she serves on a number of editorial boards.
Protein & cell, January 1, 2016
Nature, May 14, 2015
Genome medicine, February 28, 2014
Science (New York, N.Y.), February 28, 2014
Science (New York, N.Y.), January 24, 2014
Genome medicine, June 27, 2013
Nature, February 28, 2013
Proceedings of the National Academy of Sciences of the United States of America, July 13, 2012
Clinical pharmacology and therapeutics, March 1, 2012
Genome medicine, October 27, 2011